Lördag 26 April | 17:49:48 Europe / Stockholm

Kalender

Est. tid*
2025-10-31 08:00 Kvartalsrapport 2025-Q3
2025-07-11 08:00 Kvartalsrapport 2025-Q2
2025-04-30 08:00 Kvartalsrapport 2025-Q1
2025-04-28 N/A X-dag ordinarie utdelning AKBM 0.00 NOK
2025-04-25 - Årsstämma
2025-02-12 - Bokslutskommuniké 2024
2024-11-01 - Kvartalsrapport 2024-Q3
2024-09-09 - X-dag ordinarie utdelning AKBM 45.00 NOK
2024-09-03 - Extra Bolagsstämma 2024
2024-07-12 - Kvartalsrapport 2024-Q2
2024-04-26 - Kvartalsrapport 2024-Q1
2024-04-17 - X-dag ordinarie utdelning AKBM 0.00 NOK
2024-04-16 - Årsstämma
2024-02-14 - Bokslutskommuniké 2023
2023-11-01 - Kvartalsrapport 2023-Q3
2023-07-14 - Kvartalsrapport 2023-Q2
2023-04-28 - Kvartalsrapport 2023-Q1
2023-04-21 - X-dag ordinarie utdelning AKBM 0.00 NOK
2023-04-20 - Årsstämma
2023-02-15 - Bokslutskommuniké 2022
2022-11-01 - Kvartalsrapport 2022-Q3
2022-07-14 - Kvartalsrapport 2022-Q2
2022-04-29 - Kvartalsrapport 2022-Q1
2022-04-21 - X-dag ordinarie utdelning AKBM 0.00 NOK
2022-04-20 - Årsstämma
2022-02-17 - Bokslutskommuniké 2021
2021-10-29 - Kvartalsrapport 2021-Q3
2021-07-14 - Kvartalsrapport 2021-Q2
2021-04-29 - Kvartalsrapport 2021-Q1
2021-03-15 - X-dag ordinarie utdelning AKBM 0.00 NOK
2021-03-12 - Årsstämma
2021-02-16 - Bokslutskommuniké 2020
2020-10-30 - Kvartalsrapport 2020-Q3
2020-07-15 - Kvartalsrapport 2020-Q2

Beskrivning

LandNorge
ListaOslo Bors
SektorHandel & varor
IndustriDagligvaror
Aker BioMarine är verksamma inom bioteknik. Bolaget är specialiserade inom utveckling av kostillskott. Produktportföljen är bred och inkluderar exempelvis omega-3 olja, näringstillskott för djur, samt proteintillskott för fiskeodling. Verksamheten drivs globalt med störst närvaro inom den nordiska marknaden. Kunderna består av både privata aktörer samt grossister. Aker BioMarine grundades år 2006 och har sitt huvudkontor i Oslo.
2025-04-02 08:15:00
2 April 2025: Reference is made to the Notice of Annual General Meeting sent on
31 March 2025. The Notice of Annual General Meeting is adjusted so i) a new
matter 7 regarding election of members to the nomination committee is included
and ii) the proposed remuneration to the Company's auditor is adjusted. The
attached notice replaces the notice dated 31 March 2025.

The annual general meeting of Aker BioMarine ASA will be held on Tuesday 25
April 2025 at 13:00 CEST.
The meeting will be conducted as a virtual meeting only, and voting will be
handled online during the meeting. Information about log-in details for the
meeting is available in the notice of the general meeting. For further
information regarding participation, please go to www.akerbiomarine/agm.

No pre-registration is needed for attending online, but attendees must be logged
in before the meeting starts. Deadline for registration of advance votes and
proxies is 24 April 2025 at 16:00 CET.

Please find attached the following documents
- Notice and Proxy forms for the Annual General Meeting 2025
- Proposed Resolutions for the Annual General Meeting 2025
- Remuneration Report 2024
- Proposal from the Nomination Committee

All documents to be processed in the meeting are available on
www.akerbiomarine/agm.

For further information, please contact
Christopher Robin Vinter, VP Strategic Finance & IR
Mobile: +47 911 60 820
Email: Christopher.vinter@akerbiomarine.com

This information is subject to the disclosure requirements pursuant to Section
5-12 the Norwegian Securities Trading Act.

About Aker BioMarine Aker BioMarine is a leading human health and nutrition
innovator that develops krill-derived products for consumer health and
nutrition. Krill is a natural, powerful, and health-promoting source of
nutrients from the pristine waters of Antarctica, and Aker BioMarine has a
unique position in its industry. The ingredient portfolio consists of Superba
Krill Oil, Lysoveta, FloraMarine, and PL+, as well as the consumer brand, Kori
Krill. The innovative approach also extends into the spin-offs AION (reduce and
recycle plastic waste across industries) and Understory (a protein brand). Aker
BioMarine is listed on the Oslo Stock Exchange (AKBM). More information is
available at www.akerbiomarine.com.